Details for 2011736500
Up to date per 03.04.2026
Actions
Details for 2011736500
Granted/Registered
European Patent
15.05.2013 A
28.10.2015 B1
06.07.2010
US
361830 P
31.08.2010
US
378837 P
A61K 9/127 20060101AFI20120125BHEP
Owner
GlaxoSmithKline Biologicals SARue de l'Institut 89 1330 RixensartBE
Representative
Representative
SONN Patentanwälte GmbH & Co KGRiemergasse 141010 WienAT
Inventor
GEALL, Andrewc/o Novartis Vaccines and Diagnostics Inc. PO Box 8097 Emeryville, CA 94662-8097US
Information about Fees